The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 3 I, 1997, Pages 901-905

  Sirgel, Frederick A ^b   Botha, Frederick J ^b   Parkin, Donald P ^b   Van De Wal, Bernard W ^b   Schall, Robert ^b   Donald, Peter R ^b   Mitchison, Denis A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ISONIAZID;

ADULT; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SPUTUM ANALYSIS; TUBERCULOSIS;

EID: 0030826265     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.3.9611066     Document Type: Article

References (27)

1. Hong Kong Chest Service/British Medical Research Council. 1987. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Am. Rev. Respir. Dis. 136:1339-1342.
2. Grzybowski, S., and D. A. Enarson. 1978. The fate of cases of pulmonary tuberculosis under various treatment programmes. Bull. I.U.A.T. 53:70-75.
3. Reider, H. L. 1993. Drug-resistant tuberculosis: issues in epidemiology and challenges for public health. Bull. Int. Union Tuberc. Lung Dis. 75:321-323.
4. Heifets, L. B., and P. J. Lindholm-Levy. 1987. Bacteriostatic and bactericidal activity of CIP and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Tubercle 68:267-278.
5. Jindani, A., V. R. Aber, E. A. Edwards, and D. A. Mitchison. 1980. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am. Rev. Respir. Dis. 121:939.
6. Sirgel, F. A., F. J. H. Botha, D. P. Parkin, B. W. Van de Wal, P. R. Donald, and D. A. Mitchison. 1994. Early bactericidal activity as a method of assessment of drugs for the treatment of tuberculosis. J. Antimicrob. Chemother. 34:181-190.
7. Sirgel, F. A., F. J. H. Botha, D. P. Parkin, B. W. Van de Wal, P. R. Donald, and D. A. Mitchison. 1993. The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment. J. Antimicrob. Chemother. 32:867-875.
8. Dean, A. G., J. A. Dean, D. Coulombier, K. A. Brendel, D. C. Smith, A. H. Burton, R. C. Dicker, K. Sullivan, R. F. Fagan, and T. G. Arner. 1994. Epi Info, version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Centers for Disease Control and Prevention, Atlanta, GA.
9. Cuzick, J. 1985. Wilcoxon-type test for trend. Stat. Med. 4:87-90.
10. Donald, P. R., F. A. Sirgel, F. J. Botha, H. I. Seifart, D. P. Parkin, M. L. Vandenplas, B. W. Van de Wal, J. S. Maritz, and D. A. Mitchison. 1997. The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 156:000-000.
11. Bergan, T., S.B. Thorsteinsson, R. Solberg, L. Bjornskau, I. M. Kolstad, and S. Johnsen. 1987. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses. Am. J. Med. 82(Suppl. 4A):97-102.
12. Dunbar, C. P., R. Ashton, L. Atkinson, et al. 1989. Clinical experience with ciprofloxacin: analysis of a multi-practice study. J. South Carolina Med. Assoc. 85:97-101.
13. Kresnicka, D., T. Lowry, P. Holzworth, S. T. Moussalli, J. Whalen, and C. White. 1991. Experience with ciprofloxacin. Iowa Med. 81:118-120.
14. Kennedy, N., R. Fox, G. M. Kisyombe, et al. 1993. Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis. Am. Rev. Respir. Dis. 148:1547-1551.
15. Kahana, M., and M. Spino. 1991. Ciprofloxacin in patients with mycobacterial infections: experience in 15 patients. Ann. Pharmacother. 25: 919-924.
16. Kennedy, N., L. Berger, J. Curram, R. Fox, J. Gutmann, G. M. Kisyombe, F. I. Ngowi, A. R. Ramsay, A. O. Saruni, N. Sam, G. Tillotson, L. O. Uiso, M. Yates, and S. H. Gillespie. 1996. Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis. Clin. Infect. Dis. 22:827-833.
17. Mohanty, K. C., and T. M. Dhamgaye. 1993. Controlled trial of ciprofloxacin in short-term chemotherapy for pulmonary tuberculosis. Chest 104:1194-1198.
18. Tsukamura, M., E. Nakamura, S. Yoshii, and H. Amano. 1985. Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis. Am. Rev. Respir. Dis. 131:352-356.
19. Hong Kong Chest Service/British Medical Research Council. 1992. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Tuberc. Lung Dis. 73:59-67.
20. Long, M. W., G. A. Snider, and L. S. Farer. 1973. U.S. Public Health Service cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis. Am. Rev. Respir. Dis. 119:879-894.
21. Mitchison, D. A. 1980. Basic mechanisms of chemotherapy. Chest 76S: 771-781.
22. Botha, F. J. H., F. A. Sirgel, D. P. Parkin, B. W. Van de Wal, P. R. Donald, and D. A. Mitchison. 1996. Early bactericidal activity of ethambutol, pyrazinamide, and the fixed combination of isoniazid, rifampicin, and pyrazinamide (Rifater) in patients with pulmonary tuberculosis. S. Afr. Med. J. 86:155-158.
23. Stutman, H. R., I. Shalit, M. I. Marks, R. Greenwood, S. A. Chartrand, and B. C. Hilman. 1987. Pharmacokinetics of two dosage regimens of ciprofloxacin during a two-week therapeutic trial in patients with cystic fibrosis. Am. J. Med. 82(Suppl. 4A):142-145.
24. Mitchison, D. A. 1992. Understanding the chemotherapy of tuberculosis: current problems. The Garrod Lecture. J. Antimicrob. Chemother. 29: 477-493.
25. Lalande, V., C. Truffot-Pernot, A. Paccaly-Moulin, J. Grosset, and J. Baohong. 1993. Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice. Antimicrob. Agents Chemother. 37:407-413.
26. Mitchison, D. A. 1995. Early bactericidal activity and sterilizing activity of ciprofloxacin in pulmonary tuberculosis (letter). Am. J. Respir. Crit. Care Med. 151:921.
27. Tuberculosis Chemotherapy Centre, Madras. 1960. A concurrent comparison of isoniazid plus PAS with three regimens of isoniazid alone in the domiciliary treatment of pulmonary tuberculosis in South India. Bull. World Health Organ. 23:535-585.